| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |